The treatment of hepatic fibrosis: Reversal of the underlying disease process

Luis Servin-Abad, Eugene R Schiff

Research output: Contribution to journalArticle

Abstract

Cirrhosis is considered an irreversible end stage of all liver diseases. Current knowledge indicates that fibrosis is part of the liver repair process, which is dynamic. Understanding this repair process will provide better approaches to halt, ameliorate, or reverse fibrosis. The diagnosis of cirrhosis is currently established by liver biopsy and in most advanced cases can be confirmed by imaging. Liver biopsy remains the gold standard but has several limitations: sampling error, size of the biopsy, and both inter- and intra-observer inconsistencies. Hence, many patients can be inaccurately staged for the degree of fibrosis on their initial biopsy, as well as on subsequent re-examination. Although a decrease of 1 stage between consecutive biopsies may be a result of sampling error, the reduction from cirrhosis by at least 2 stages more likely represents a reversal of cirrhosis. There are several cases of reversal of cirrhosis reported in association with different liver diseases. The resolution of fibrosis in the majority of these diseases is related to successful treatment of the underlying etiology (eg, hepatitis B, hepatitis C, iron overload, Wilson disease, alcohol abstinence, metabolic syndrome in fatty liver disease, and decompression of biliary obstruction). The other important feature of reversal of cirrhosis is the successful control of inflammation (eg, autoimmune hepatitis, primary biliary cirrhosis, hepatitis B, C, and D).

Original languageEnglish
Pages (from-to)819-825
Number of pages7
JournalGastroenterology and Hepatology
Volume2
Issue number11
StatePublished - Nov 1 2006

Fingerprint

Fibrosis
Liver
Biopsy
Therapeutics
Selection Bias
Hepatitis C
Hepatitis B
Liver Diseases
Alcohol Abstinence
Hepatitis D
Autoimmune Hepatitis
Hepatolenticular Degeneration
End Stage Liver Disease
Iron Overload
Biliary Liver Cirrhosis
Fatty Liver
Decompression
Inflammation

Keywords

  • Biliary obstruction
  • Cirrhosis reversal
  • Fibrosis regression
  • Hepatitis
  • Nonalcoholic steatohepatitis

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

The treatment of hepatic fibrosis : Reversal of the underlying disease process. / Servin-Abad, Luis; Schiff, Eugene R.

In: Gastroenterology and Hepatology, Vol. 2, No. 11, 01.11.2006, p. 819-825.

Research output: Contribution to journalArticle

@article{fd5e7866297542ba80ec336c0c4dbbbc,
title = "The treatment of hepatic fibrosis: Reversal of the underlying disease process",
abstract = "Cirrhosis is considered an irreversible end stage of all liver diseases. Current knowledge indicates that fibrosis is part of the liver repair process, which is dynamic. Understanding this repair process will provide better approaches to halt, ameliorate, or reverse fibrosis. The diagnosis of cirrhosis is currently established by liver biopsy and in most advanced cases can be confirmed by imaging. Liver biopsy remains the gold standard but has several limitations: sampling error, size of the biopsy, and both inter- and intra-observer inconsistencies. Hence, many patients can be inaccurately staged for the degree of fibrosis on their initial biopsy, as well as on subsequent re-examination. Although a decrease of 1 stage between consecutive biopsies may be a result of sampling error, the reduction from cirrhosis by at least 2 stages more likely represents a reversal of cirrhosis. There are several cases of reversal of cirrhosis reported in association with different liver diseases. The resolution of fibrosis in the majority of these diseases is related to successful treatment of the underlying etiology (eg, hepatitis B, hepatitis C, iron overload, Wilson disease, alcohol abstinence, metabolic syndrome in fatty liver disease, and decompression of biliary obstruction). The other important feature of reversal of cirrhosis is the successful control of inflammation (eg, autoimmune hepatitis, primary biliary cirrhosis, hepatitis B, C, and D).",
keywords = "Biliary obstruction, Cirrhosis reversal, Fibrosis regression, Hepatitis, Nonalcoholic steatohepatitis",
author = "Luis Servin-Abad and Schiff, {Eugene R}",
year = "2006",
month = "11",
day = "1",
language = "English",
volume = "2",
pages = "819--825",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "11",

}

TY - JOUR

T1 - The treatment of hepatic fibrosis

T2 - Reversal of the underlying disease process

AU - Servin-Abad, Luis

AU - Schiff, Eugene R

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Cirrhosis is considered an irreversible end stage of all liver diseases. Current knowledge indicates that fibrosis is part of the liver repair process, which is dynamic. Understanding this repair process will provide better approaches to halt, ameliorate, or reverse fibrosis. The diagnosis of cirrhosis is currently established by liver biopsy and in most advanced cases can be confirmed by imaging. Liver biopsy remains the gold standard but has several limitations: sampling error, size of the biopsy, and both inter- and intra-observer inconsistencies. Hence, many patients can be inaccurately staged for the degree of fibrosis on their initial biopsy, as well as on subsequent re-examination. Although a decrease of 1 stage between consecutive biopsies may be a result of sampling error, the reduction from cirrhosis by at least 2 stages more likely represents a reversal of cirrhosis. There are several cases of reversal of cirrhosis reported in association with different liver diseases. The resolution of fibrosis in the majority of these diseases is related to successful treatment of the underlying etiology (eg, hepatitis B, hepatitis C, iron overload, Wilson disease, alcohol abstinence, metabolic syndrome in fatty liver disease, and decompression of biliary obstruction). The other important feature of reversal of cirrhosis is the successful control of inflammation (eg, autoimmune hepatitis, primary biliary cirrhosis, hepatitis B, C, and D).

AB - Cirrhosis is considered an irreversible end stage of all liver diseases. Current knowledge indicates that fibrosis is part of the liver repair process, which is dynamic. Understanding this repair process will provide better approaches to halt, ameliorate, or reverse fibrosis. The diagnosis of cirrhosis is currently established by liver biopsy and in most advanced cases can be confirmed by imaging. Liver biopsy remains the gold standard but has several limitations: sampling error, size of the biopsy, and both inter- and intra-observer inconsistencies. Hence, many patients can be inaccurately staged for the degree of fibrosis on their initial biopsy, as well as on subsequent re-examination. Although a decrease of 1 stage between consecutive biopsies may be a result of sampling error, the reduction from cirrhosis by at least 2 stages more likely represents a reversal of cirrhosis. There are several cases of reversal of cirrhosis reported in association with different liver diseases. The resolution of fibrosis in the majority of these diseases is related to successful treatment of the underlying etiology (eg, hepatitis B, hepatitis C, iron overload, Wilson disease, alcohol abstinence, metabolic syndrome in fatty liver disease, and decompression of biliary obstruction). The other important feature of reversal of cirrhosis is the successful control of inflammation (eg, autoimmune hepatitis, primary biliary cirrhosis, hepatitis B, C, and D).

KW - Biliary obstruction

KW - Cirrhosis reversal

KW - Fibrosis regression

KW - Hepatitis

KW - Nonalcoholic steatohepatitis

UR - http://www.scopus.com/inward/record.url?scp=53649103122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53649103122&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:53649103122

VL - 2

SP - 819

EP - 825

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 11

ER -